Valion Bio, Inc. Interest Expense
Valion Bio, Inc. (VBIO) reported Interest Expense of $223.00 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2022-08-15
- Valion Bio, Inc. interest expense for the quarter ending 2021-06-30 was $223.00K.
- Valion Bio, Inc. interest expense for the quarter ending 2021-03-31 was $274.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month |
|---|---|---|
| 2021-06-30 | $223.00K 10-Q · filed 2022-08-15 | $497.00K 10-Q · filed 2022-08-15 |
| 2021-03-31 | $274.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |